Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lundbeck Wants To Stop US Prisons Getting Epilepsy Drug
WSJ Online
Wednesday, June 8, 2011 - 8:56am
tags:
epilepsy, Lundbeck, execution drugs
Biogen Seeking Deals to Expand Pipeline of MS Treatments
Bloomberg
Wednesday, June 8, 2011 - 8:53am
tags:
MS, multiple sclerosis, Biogen Idec
Covidien Said to Work With JPMorgan Seeking Buyer for Drug Unit
Bloomberg
Wednesday, June 8, 2011 - 8:52am
tags:
Covidien, M&A
India Proposes Tougher Code On Pharma Freebies
Pharmalot
Wednesday, June 8, 2011 - 8:51am
tags:
India, physician gifts
Pharmacyclics Shares Popped: What You Need to Know
Motley Fool
Wednesday, June 8, 2011 - 8:50am
tags:
Pharmacyclics, tyrosine kinases
Health-Care Law Must Stand, U.S. Says in Third Appeal Argument
Bloomberg
Wednesday, June 8, 2011 - 8:31am
tags:
healthcare reform
Biomarin - Fair Value of $50+: A Step-by-Step Analysis
Seeking Alpha
Wednesday, June 8, 2011 - 8:30am
tags:
Biomarin
Merck ends trial of Intercell's MRSA vaccine
Yahoo/AP
Wednesday, June 8, 2011 - 8:29am
tags:
Intercell, vaccines, Merkc, MRSA, V710
A Dull ASCO And The Usual Sell-Off
Investopedia
Tuesday, June 7, 2011 - 7:34pm
tags:
ASCO, Celgene, Bristol-Myers Squibb, Incyte, Exelixis, Novartis, YM BioSciences, Neoprobe
ASCO studies shake up drug stocks
Marketwatch
Tuesday, June 7, 2011 - 6:22pm
tags:
ASCO, drug stocks, Sunesis, Exelixis, Bayer, Oxigene, Regeneron, EntreMed
Merck and Roche: Sometimes a Partnership Feels Personal
Motley Fool
Tuesday, June 7, 2011 - 6:18pm
tags:
Merck, Roche, cancer, diagnostics
Pfizer starts first US "virtual" clinical study, under pilot FDA program using Internet
Yahoo/AP
Tuesday, June 7, 2011 - 6:16pm
tags:
clinical studies, Pfizer, FDA, Detrol, overactive bladder
APP launches generic version of Femara, drug linked to lower breast cancer risk in new study
Yahoo/AP
Tuesday, June 7, 2011 - 6:15pm
tags:
APP, Femara, breast cancer, generics, Novartis
Pfizer May Seek $1 Billion in Yearly Cost Cuts, WSJ Says
Bloomberg
Tuesday, June 7, 2011 - 6:14pm
tags:
Pfizer
FDA allows Actavis to market generic insomnia drug
Pharmaceutical Business Review
Tuesday, June 7, 2011 - 10:08am
tags:
FDA, Actavis, Ambien CR, insomnia, generics
Sanofi preps for new pivotal trial of a blockbuster hopeful
Fierce Biotech
Tuesday, June 7, 2011 - 10:01am
tags:
Sanofi, iniparib, breast cancer
Remark Haunts Drug Company in Overtime Pay Suit
BNET Pharma
Tuesday, June 7, 2011 - 9:58am
tags:
Endo, overtime lawsuits, drug reps
Biogen says European Union regulators approved once-a-week injection pen for MS
Yahoo/AP
Tuesday, June 7, 2011 - 9:54am
tags:
Biogen Idec, Europe, MS, multiple sclerosis, Avonex pen
Novo Nordisk: Convenient Diabetes Care Could Drive Growth
Seeking Alpha
Tuesday, June 7, 2011 - 9:52am
tags:
diabetes, Novo Nordisk
Analyst says Aeterna Zentaris shares could double on cancer drug development and approval
Yahoo/AP
Tuesday, June 7, 2011 - 9:51am
tags:
Aeterna Zentaris, perifosine

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.